#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1054500	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
2.	ALA1054501	F	GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
3.	ALA1054502	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
4.	ALA1054503	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
5.	ALA1054504	F	GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.	Homo sapiens	13,467	ALA1157539	cell-based format	GSK Malaria Screening
6.	ALA1054505	F	GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested		13,467	ALA1157539	assay format	GSK Malaria Screening
7.	ALA3436039	F	ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro	Leishmania mexicana	791	ALA3433997	assay format	St Jude Leishmania Screening
8.	ALA3436040	F	ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro	Leishmania mexicana	791	ALA3433997	assay format	St Jude Leishmania Screening
9.	ALA3436041	F	ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro	Leishmania mexicana	791	ALA3433997	assay format	St Jude Leishmania Screening
10.	ALA3436042	F	ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro	Leishmania mexicana	13,179	ALA3433997	assay format	St Jude Leishmania Screening
11.	ALA3436043	F	ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro	Leishmania mexicana	13,179	ALA3433997	assay format	St Jude Leishmania Screening
12.	ALA3436044	F	ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro	Leishmania mexicana	13,179	ALA3433997	assay format	St Jude Leishmania Screening
13.	ALA3738285	B	Inhibition of DHFR in mouse L1210 cells using dihydrofolate as substrate preincubated for 5 mins followed by substrate addition by spectrofluorometric analysis	Mus musculus	1	ALA3734661	cell-based format	Scientific Literature
14.	ALA3739008	B	Inhibition of rat DHFR extracted from liver using dihydrofolate as substrate preincubated for 5 mins followed by substrate addition by spectrofluorometric analysis	Rattus norvegicus	1	ALA3734661	assay format	Scientific Literature
15.	ALA3739009	B	Inhibition of DHFR in Crithidia oncopelti using dihydrofolate as substrate preincubated for 5 mins followed by substrate addition by spectrofluorometric analysis	Crithidia fasciculata	1	ALA3734661	assay format	Scientific Literature
16.	ALA3739010	B	Inhibition of DHFR in Lactobacillus casei using dihydrofolate as substrate preincubated for 5 mins followed by substrate addition by spectrofluorometric analysis	Lacticaseibacillus casei	1	ALA3734661	single protein format	Scientific Literature
17.	ALA3739015	F	Cytotoxicity against mouse L1210 cells assessed as growth inhibition after 48 hrs by MTT assay	Mus musculus	1	ALA3734661	cell-based format	Scientific Literature
18.	ALA4146153	F	Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in human THP1 cells after 5 days by Steady-Glo luminescence assay	Mycobacterium tuberculosis	3	ALA4145451	organism-based format	Scientific Literature
19.	ALA4146154	B	Inhibition of Mycobacterium tuberculosis H37Rv DHFR expressed in Escherichia coli assessed as reduction in consumption of NADPH using DHF as substrate by fluorescence method	Mycobacterium tuberculosis H37Rv	3	ALA4145451	assay format	Scientific Literature
20.	ALA4146155	B	Inhibition of human DHFR assessed as reduction in consumption of NADPH using DHF as substrate by fluorescence method	Homo sapiens	3	ALA4145451	single protein format	Scientific Literature